Terns Pharmaceuticals
TERN
TERN
128 hedge funds and large institutions have $310M invested in Terns Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
-9
Holders Change %
-6.57%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
48
Reduced
30
Closed
32
Calls
$910K
Puts
$399K
Net Calls
+$511K
Net Calls Change
-$68K
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$7.16M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.77M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$4.76M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$890K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$799K |
Top Sellers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.97M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.11M |
| 3 |
Renaissance Technologies
New York
|
-$1.91M |
| 4 |
Barclays
London,
United Kingdom
|
-$1.52M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.34M |
